Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab
Clinical trial NCT07041268 · RECRUITING
Trial details
- NCT number
- NCT07041268
- Sponsor
- Pirogov Russian National Research Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2027-12-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.